AMPH vs. AVGO
Compare and contrast key facts about Amphastar Pharmaceuticals, Inc. (AMPH) and Broadcom Inc. (AVGO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AMPH or AVGO.
Correlation
The correlation between AMPH and AVGO is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
AMPH vs. AVGO - Performance Comparison
Key characteristics
AMPH:
-1.06
AVGO:
0.94
AMPH:
-1.58
AVGO:
1.71
AMPH:
0.80
AVGO:
1.23
AMPH:
-0.65
AVGO:
1.47
AMPH:
-1.51
AVGO:
4.08
AMPH:
27.99%
AVGO:
14.82%
AMPH:
39.33%
AVGO:
62.86%
AMPH:
-64.63%
AVGO:
-48.30%
AMPH:
-62.08%
AVGO:
-16.42%
Fundamentals
AMPH:
$1.16B
AVGO:
$943.78B
AMPH:
$3.06
AVGO:
$2.16
AMPH:
8.01
AVGO:
92.93
AMPH:
2.77
AVGO:
0.54
AMPH:
1.63
AVGO:
17.31
AMPH:
1.63
AVGO:
13.72
AMPH:
$558.19M
AVGO:
$42.04B
AMPH:
$280.64M
AVGO:
$27.50B
AMPH:
$203.23M
AVGO:
$19.89B
Returns By Period
In the year-to-date period, AMPH achieves a -33.61% return, which is significantly lower than AVGO's -10.11% return. Over the past 10 years, AMPH has underperformed AVGO with an annualized return of 5.38%, while AVGO has yielded a comparatively higher 36.25% annualized return.
AMPH
-33.61%
3.79%
-46.52%
-41.60%
5.60%
5.38%
AVGO
-10.11%
33.16%
13.68%
58.68%
53.93%
36.25%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AMPH vs. AVGO — Risk-Adjusted Performance Rank
AMPH
AVGO
AMPH vs. AVGO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Amphastar Pharmaceuticals, Inc. (AMPH) and Broadcom Inc. (AVGO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
AMPH vs. AVGO - Dividend Comparison
AMPH has not paid dividends to shareholders, while AVGO's dividend yield for the trailing twelve months is around 1.08%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMPH Amphastar Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
AVGO Broadcom Inc. | 1.08% | 0.94% | 1.71% | 3.02% | 2.24% | 3.05% | 3.54% | 3.11% | 1.87% | 1.43% | 1.13% | 1.22% |
Drawdowns
AMPH vs. AVGO - Drawdown Comparison
The maximum AMPH drawdown since its inception was -64.63%, which is greater than AVGO's maximum drawdown of -48.30%. Use the drawdown chart below to compare losses from any high point for AMPH and AVGO. For additional features, visit the drawdowns tool.
Volatility
AMPH vs. AVGO - Volatility Comparison
The current volatility for Amphastar Pharmaceuticals, Inc. (AMPH) is 13.65%, while Broadcom Inc. (AVGO) has a volatility of 21.71%. This indicates that AMPH experiences smaller price fluctuations and is considered to be less risky than AVGO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
AMPH vs. AVGO - Financials Comparison
This section allows you to compare key financial metrics between Amphastar Pharmaceuticals, Inc. and Broadcom Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AMPH vs. AVGO - Profitability Comparison
AMPH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Amphastar Pharmaceuticals, Inc. reported a gross profit of 86.65M and revenue of 186.98M. Therefore, the gross margin over that period was 46.3%.
AVGO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Broadcom Inc. reported a gross profit of 10.15B and revenue of 14.92B. Therefore, the gross margin over that period was 68.0%.
AMPH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Amphastar Pharmaceuticals, Inc. reported an operating income of 45.14M and revenue of 186.98M, resulting in an operating margin of 24.1%.
AVGO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Broadcom Inc. reported an operating income of 6.26B and revenue of 14.92B, resulting in an operating margin of 42.0%.
AMPH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Amphastar Pharmaceuticals, Inc. reported a net income of 37.96M and revenue of 186.98M, resulting in a net margin of 20.3%.
AVGO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Broadcom Inc. reported a net income of 5.50B and revenue of 14.92B, resulting in a net margin of 36.9%.